Literature DB >> 3278016

Haemorrhagic colitis: detection of verotoxin producing Escherichia coli O157 in a clinical microbiology laboratory.

C W Walker1, R Upson, R E Warren.   

Abstract

Faeces (n = 1319) were examined over three months for the presence of non-sorbitol fermenting, verotoxin producing Escherichia coli (serotype O157). Seven isolates were found, four from patients with bloodstained diarrhoea and three from patients with no evidence of blood in the faeces. Screening of all faecal samples with specific O157 antiserum for non-sorbitol fermenting organisms and agglutination was an important adjunct to clinical and microscopic findings and helped detect cases of verotoxin producing E coli which might otherwise have been missed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3278016      PMCID: PMC1141339          DOI: 10.1136/jcp.41.1.80

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  21 in total

1.  Activity of lysine decarboxlase as an aid in the identification of Salmonellae and Shigellae.

Authors:  S FALKOW
Journal:  Am J Clin Pathol       Date:  1958-06       Impact factor: 2.493

2.  Two distinct toxins active on Vero cells from Escherichia coli O157.

Authors:  S M Scotland; H R Smith; B Rowe
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

3.  Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features.

Authors:  C H Pai; R Gordon; H V Sims; L E Bryan
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

4.  Vero response to a cytotoxin of Escherichia coli.

Authors:  J Konowalchuk; J I Speirs; S Stavric
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

5.  Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.

Authors:  M A Karmali; B T Steele; M Petric; C Lim
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

6.  Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin.

Authors:  A O O'Brien; T A Lively; M E Chen; S W Rothman; S B Formal
Journal:  Lancet       Date:  1983-03-26       Impact factor: 79.321

7.  Hemorrhagic colitis associated with a rare Escherichia coli serotype.

Authors:  L W Riley; R S Remis; S D Helgerson; H B McGee; J G Wells; B R Davis; R J Hebert; E S Olcott; L M Johnson; N T Hargrett; P A Blake; M L Cohen
Journal:  N Engl J Med       Date:  1983-03-24       Impact factor: 91.245

8.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

9.  Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype.

Authors:  J G Wells; B R Davis; I K Wachsmuth; L W Riley; R S Remis; R Sokolow; G K Morris
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

10.  Survival and growth characteristics of Escherichia coli associated with hemorrhagic colitis.

Authors:  M P Doyle; J L Schoeni
Journal:  Appl Environ Microbiol       Date:  1984-10       Impact factor: 4.792

View more
  8 in total

1.  Vero toxin producing E coli in haemorrhagic colitis.

Authors:  E Larson; A Welch
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

2.  The use of sorbitol-MacConkey agar in conjunction with a specific antiserum for the detection of Vero cytotoxin-producing strains of Escherichia coli O 157.

Authors:  H Kleanthous; N K Fry; H R Smith; R J Gross; B Rowe
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

3.  Clinical and pathological variability of infection by enterohaemorrhagic (Vero cytotoxin producing) Escherichia coli.

Authors:  C M Hunt; J A Harvey; E R Youngs; S T Irwin; T M Reid
Journal:  J Clin Pathol       Date:  1989-08       Impact factor: 3.411

4.  Haemorrhagic colitis and Escherichia coli O157--a pathogen unmasked.

Authors:  J Symonds
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-26

5.  The isolation rate of Escherichia coli 0157:H7 in Toronto and surrounding communities.

Authors:  A E Simor; C Watt; D E Low
Journal:  Can J Infect Dis       Date:  1990

6.  Results of screening for verocytotoxin-producing Escherichia coli in faeces in Belgium.

Authors:  D Piérard; R Van Etterijck; J Breynaert; L Moriau; S Lauwers
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

7.  Sorbitol-negative phenotype among enterohemorrhagic Escherichia coli strains of different serotypes and from different sources.

Authors:  A Ojeda; V Prado; J Martinez; C Arellano; A Borczyk; W Johnson; H Lior; M M Levine
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

8.  Prospective study of verocytotoxin-producing, enteroaggregative and diffusely adherent Escherichia coli in different diarrhoeal states.

Authors:  M G Brook; H R Smith; B A Bannister; M McConnell; H Chart; S M Scotland; A Sawyer; M Smith; B Rowe
Journal:  Epidemiol Infect       Date:  1994-02       Impact factor: 2.451

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.